Allen Feng, PhD, chief scientific officer, HebeCell, discussed the company’s NK cell technologies.
Allen Feng, PhD
Advertisement
Chief Scientific Officer, HebeCell Corp
Articles by Allen Feng, PhD
Allen Feng, PhD, chief scientific officer, HebeCell, discussed advantages of induced pluripotent over hematopoietic stem cell therapies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Quarter Century Update: Future Predictions for the Field
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
